Inherited variations in proteins of the nervous system have been hypothesized to underlie differences in mood, behavior, neurophysiology, neuroanatomy and response to drugs in normal individuals, as well as in neurologic and psychiatric patients. These studies will focus on the two neural proteins, catechol-0-methyltransferase (COMT) and Beta-nerve growth factor (Beta-NGF) which are amenable to biochemical and genetic analysis for which inherited variations in function are thought to occur in humans. For COMT, the number, location and structure of human genes coding for multiple forms of this enzyme will be assessed. Further, it will be established whether inherited variations in COMT activity, measured in red blood cell lysates and thought to affect drug metabolism, are caused by allelic variations in structural gene locus for this enzyme. This will elucidate the relationship between multiple forms of COMT, and the molecular basis of normal variations in activity. The role of Beta-NGF in the inherited neurologic disease, familial dysautonomia, will be assessed by establishing whether or not specific alleles for the structural gene are co-inherited with the disease state in affected families. Further, a source of authentic human Beta-NGF will be sought using antibodies prepared against recombinant human """"""""Beta-NGF"""""""" and a cloned DNA probe for the human Beta-NGF mRNA. By characterizing the authentic form of this human protein it will be possible to investigate its role in other neurologic diseases. Methods to be employed include protein biochemistry, e.g. gel electrophoresis, peptide mapping, microsequencing; immunological techniques, e.g. immunoblotting, immune precipitation, immunoaffinity adsorption of polysomes, radioimmunoassays; molecular biologic techniques, e.g. in vitro translation of mRNA, cDNA cloning in expression and non-expression plasmids, restriction endonuclease mapping, nucleotide sequencing, Southern and Northern blotting; and cell culture procedures, e.g. transformation of lymphocytes, analysis of somatic cell hybrids, radioreceptor assays.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM034536-02
Application #
3285717
Study Section
Neurology B Subcommittee 1 (NEUB)
Project Start
1984-08-01
Project End
1987-07-31
Budget Start
1985-08-01
Budget End
1986-07-31
Support Year
2
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Eunice Kennedy Shriver Center Mtl Retardatn
Department
Type
DUNS #
City
Waltham
State
MA
Country
United States
Zip Code
Shimohama, S; Rosenberg, M B; Fagan, A M et al. (1989) Grafting genetically modified cells into the rat brain: characteristics of E. coli beta-galactosidase as a reporter gene. Brain Res Mol Brain Res 5:271-8
Wolf, D; Richter-Landsberg, C; Short, M P et al. (1988) Retrovirus-mediated gene transfer of beta-nerve growth factor into mouse pituitary line AtT-20. Mol Biol Med 5:43-59
Rosenberg, M B; Breakefield, X O; Hawrot, E (1987) Targeting of liposomes to cells bearing nerve growth factor receptors mediated by biotinylated nerve growth factor. J Neurochem 48:865-75
Breakefield, X O; Geller, A I (1987) Gene transfer into the nervous system. Mol Neurobiol 1:339-71
Breakefield, X O; Cambi, F (1987) Molecular genetic insights into neurologic diseases. Annu Rev Neurosci 10:535-94
Seizinger, B R; Martuza, R L; Rouleau, G et al. (1987) Models for inherited susceptibility to cancer in the nervous system: a molecular-genetic approach to neurofibromatosis. Dev Neurosci 9:144-53
Rosenberg, M B; Hawrot, E; Breakefield, X O (1986) Receptor binding activities of biotinylated derivatives of beta-nerve growth factor. J Neurochem 46:641-8
Breakefield, X O; Ozelius, L; Bothwell, M A et al. (1986) DNA polymorphisms for the nerve growth factor receptor gene exclude its role in familial dysautonomia. Mol Biol Med 3:483-94
Brockes, J P; Breakefield, X O; Martuza, R L (1986) Glial growth factor-like activity in Schwann cell tumors. Ann Neurol 20:317-22
Rosenberg, M B; Hansen Jr, C; Breakefield, X O (1985) Molecular genetic approaches to neurologic and psychiatric diseases. Prog Neurobiol 24:95-140